19yo California law student complains of vomiting. Hours later, a nurse finds her dead next to an empty vial of medicine

California native Josephine Elaria George Nasr was a 19-year-old law student with her best years seemingly ahead of her. But on the night of Sept. 23, 2025, Nasr was unexpectedly found dead on the bathroom floor of her university dorm room in London. The official UK coroner’s inquest into her death was finally completed and released in August 2026, and its findings suggest that a GLP-1 weight-loss drug may have played a role.

According to People, Nasr was a second-year international law student at the University of East London at the time of her death. On that night, she had administered a dose of Zepbound, a weight-loss medication containing the active ingredient tirzepatide. Shortly after taking the drug, Nasr experienced severe, continuous vomiting and physical distress.

She had been prescribed the medication during the summer break while staying at her family’s home in Corona, California. Before she collapsed from her symptoms, she called home at 8:30 p.m. to tell her family that the medication was making her feel unwell.

She was pronounced dead at the scene

Initially, her parents, George Nasr and Lorin Mansour, and her sister, Anastasia, who were back home in California, told her to go outside, get some fresh air and see if that helped. Anastasia took matters a step further and contacted a private medical provider in London to arrange for a nurse to visit Nasr and assess her condition.

Eventually, calls from the family went unanswered. When the nurse arrived at Nasr’s campus flat, university staff directed her to the room where Nasr was staying. That’s when the nurse discovered Nasr lying on the bathroom floor next to a vial of the medication. Emergency services were immediately called to the room, but Nasr was pronounced dead at the scene.

GLP-1 medications have become some of the most discussed and controversial drugs in modern culture. Originally developed for patients with Type 2 diabetes, the medications were later found to have significant effects on weight management, leading to their widespread use for weight loss. Nasr’s tragic death now adds another chapter to the ongoing debate over their risks and regulation.

The post-mortem examination and subsequent inquest identified two distinct factors that combined to cause Nasr’s death: a congenital structural abnormality and an acute metabolic crisis.

The autopsy revealed that Nasr had an undiagnosed congenital condition known as myocardial bridging. This occurs when a major artery runs through the heart muscle rather than along its surface. Until then, the condition had apparently been asymptomatic.

The combination of the two conditions proved too severe

However, the inquest determined that the vomiting was associated with hypoglycemia, a condition in which blood sugar drops to dangerously low levels. The coroner ruled that if Nasr’s heart had been structurally typical, she might have been able to withstand the physiological strain caused by the metabolic crisis. But the combination of the two conditions proved too severe for her body.

In the UK, the number of deaths in which weight-loss medications have been cited as a factor has now surpassed 100 cases.